Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-22 4:33 pm Purchase | 2024-05-14 | 13G | MiNK Therapeutics, Inc. INKT | GKCC LLC | 464,000 11.790% | 464,000 (New Position) | Filing History |
| 2024-02-14 6:05 pm Purchase | 2024-01-16 | 13D | MiNK Therapeutics, Inc. INKT | ARMEN GARO H | 351,432 9.680% | 89,744 (+34.29%) | Filing History |
| 2023-05-26 5:03 pm Purchase | 2023-05-19 | 13D | MiNK Therapeutics, Inc. INKT | AGENUS INC AGEN | 2,152,216 62.500% | 17,747 (+0.83%) | Filing History |
| 2023-05-03 5:23 pm Sale | 2023-05-01 | 13D | MiNK Therapeutics, Inc. INKT | AGENUS INC AGEN | 2,134,469 62.000% | -498,827 (-18.94%) | Filing History |
| 2022-02-14 4:06 pm Purchase | 2021-12-31 | 13G | MiNK Therapeutics, Inc. INKT | ARMEN GARO H | 261,688 7.820% | 261,688 (New Position) | Filing History |
| 2021-10-28 4:30 pm Purchase | 2021-10-19 | 13D | MiNK Therapeutics, Inc. INKT | AGENUS INC AGEN | 2,633,296 79.800% | 2,633,296 (New Position) | Filing History |